TABLE 1.
Marker | Degree of expression (mean ± standard deviation); n = 23 samples |
---|---|
PD-L1 overall* | 1.4 ± 0.9 (n = 23); expression was 0 in 2 samples |
PD-L1 tumor | 0.73 ± 1.1 |
PD-L1 stroma | 1.1 ± 1.1 |
PD-L1 endothelium | 0.96 ± 1.1 |
PD-L2 overall† | 0.83 ± 1.1 (n = 23); expression was 0 in 4 samples |
PD-L2 tumor | 0.22 ± 0.85 |
PD-L2 stroma | 0.87 ± 1.2 |
PD-L2 endothelium | 0.04 ± 0.21 |
CD8 overall‡ | 1.1 ± 0.51 (n = 23); expression was 0 in 2 samples |
CD8 tumor | 0.39 ± 0.5 |
CD8 stroma | 1.3 ± 0.62 |
Combined positive score | Degree of expression (mean ± standard deviation); n = 23 samples |
PD-L1 ≥ 1 | 57% (n = 13 samples) |
PD-L1 < 1 | 43% (n = 10 samples) |
PD-L1 scored on a 0–5 scale.
PD-L2 scored on a 0–5 scale.
CD8 scored on a 0–3 scale.
PD-L, programmed celi death ligand.